1. Home
  2. NAII vs APLT Comparison

NAII vs APLT Comparison

Compare NAII & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natural Alternatives International Inc.

NAII

Natural Alternatives International Inc.

HOLD

Current Price

$4.77

Market Cap

21.2M

Sector

Health Care

ML Signal

HOLD

Logo Applied Therapeutics Inc.

APLT

Applied Therapeutics Inc.

HOLD

Current Price

$0.10

Market Cap

18.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAII
APLT
Founded
1980
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.2M
18.0M
IPO Year
1987
2019

Fundamental Metrics

Financial Performance
Metric
NAII
APLT
Price
$4.77
$0.10
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$1.25
AVG Volume (30 Days)
16.4K
11.6M
Earning Date
02-13-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$134,440,000.00
$1,000,000.00
Revenue This Year
N/A
$124.18
Revenue Next Year
N/A
$25.00
P/E Ratio
N/A
N/A
Revenue Growth
19.00
N/A
52 Week Low
$2.57
$0.09
52 Week High
$4.96
$1.50

Technical Indicators

Market Signals
Indicator
NAII
APLT
Relative Strength Index (RSI) 76.30 28.21
Support Level $4.43 $0.09
Resistance Level $4.80 $0.10
Average True Range (ATR) 0.24 0.01
MACD 0.10 0.02
Stochastic Oscillator 88.20 34.74

Price Performance

Historical Comparison
NAII
APLT

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: